MediXall Group Delays Annual SEC Filing

MediXall Group ( (MDXL) ) has released a notification of late filing.

MediXall Group, Inc. has filed a Form 12b-25 to notify investors that it will be late in submitting its Form 10-K (Yearly Report) for the financial year ended December 31, 2025. The delayed filing concerns the company’s annual report with the U.S. securities regulator.

The company cites difficulty in obtaining certain financial and other information needed to fully and accurately complete the Form 10-K (Yearly Report) within the normal deadline. Management states that providing this information on time would have required unreasonable effort or expense, but does not point to any auditor change, internal control failure, or special committee review.

MediXall Group indicates that it expects to file the overdue Form 10-K (Yearly Report) within the 15-day extension period allowed under the Form 12b-25 rules. The company also notes that it is working on its missing Form 10-Q (Quarter Report) filings for the quarters ended March 31, June 30, and September 30, 2025.

The company confirms that it does not anticipate any significant change in its results of operations compared with the prior fiscal year in the earnings statements that will appear in the delayed Form 10-K (Yearly Report). As with all such notices, these expectations are forward-looking and could differ from the final audited numbers once the reports are completed.

MediXall Group says it is actively preparing the outstanding annual and quarterly reports to bring its SEC filings up to date and return to full compliance. The notification is signed on behalf of the company by Chief Financial Officer Travis Jackson, dated March 31, 2026, underscoring management’s responsibility for the timing and accuracy of the filings.

More about MediXall Group

Technical Sentiment Signal: Sell

Current Market Cap: $41.1K

For an in-depth examination of MDXL stock, go to TipRanks’ Overview page.